David J. Gregory Joins PetVivo Holdings, Inc. as the Regional Sales Manager
March 16 2022 - 7:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging
biomedical device company focused on the commercialization of
innovative medical devices and therapeutics for companion animals
is pleased to announce that David J. Gregory has accepted a
position with the Company as its new Regional Sales Manager for the
Midwest Region of the United States.
"We are incredibly excited about adding David to
our sales and distribution team. We believe David will be a primary
contributor to meeting our corporate goals related to sales and
distribution of our revolutionary product Spryng™ with
OsteoCushion™ technology,” said John Lai, Chief Executive Officer
of PetVivo Holdings, Inc. “David is excellent in promoting and
selling veterinary products. We are confident that these skills
will propel the sale of our veterinary medical device, Spryng, for
use in companion animals."
Mr. Gregory has more than 30 years of experience
related to management, distribution and manufacturing of veterinary
products in the United States. He has served in various roles in
farm management, product development, product distribution,
technical sales, marketing and supply chain management with
companies such as Vescor Veterinary Supply, Midwest Veterinary
Supply, DVM Resources, and Novartis Animal Health. Mr. Gregory has
further worked as a consultant for numerous farm operations with a
focus on equine and mixed animal.
“I am thrilled to have the opportunity to join
the PetVivo sales and marketing team. It is a pleasure to be part
of a company that possesses technology that has been shown to
improve the medical outcomes of animals suffering from lameness and
other joint related afflictions, such as osteoarthritis,” said Mr.
Gregory. “PetVivo’s technology has tremendous potential to enhance
the lives of companion animals and their owners.”
For more information about PetVivo Holdings,
Inc. and its innovative product, Spryng, please contact
info1@petvivo.com or visit https://petvivo.com/ and
https://sprynghealth.com/.
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV) is an
emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG, a
veterinarian-administered, intraarticular injection for the
treatment of lameness and other joint related afflictions,
including osteoarthritis, in dogs and horses, is currently
available for commercial sale to veterinarians.
CONTACT:
John Lai, CEOPetVivo Holdings, Inc.Email:
info1@petvivo.com(952) 405-6216
Forward-Looking commercial
Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements,
including the potential listing of the Company’s common stock on
Nasdaq, are based on information currently available the Company
and its current plans or expectations and are subject to a number
of uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2021 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Mar 2024 to Apr 2024
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Apr 2023 to Apr 2024